A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumour-infiltrating lymphocytes, present in the tumours of patients...
Original Article: Immune response to ovarian cancer may predict survival
NEXT ARTICLE